We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 11,848

Two key takeaways from the FTC’s consumer product warranty rule review process
  • Arnold & Porter LLP
  • USA
  • May 27 2015

Last week, the FTC announced that after completing its review of the FTC rules governing consumer product warranties under the Magnuson-Moss Warranty


FDA and the FTC unfriend a dietary supplement product
  • Arnall Golden Gregory LLP
  • USA
  • May 27 2015

In an interesting Warning Letter recently issued, both the Food and Drug Administration and the Federal Trade Commission issued a Warning Letter to a


Former senior executives indicted for illegal marketing of a medical device
  • Arnall Golden Gregory LLP
  • USA
  • May 27 2015

Two former senior executives were indicted with violations of the Food, Drug, and Cosmetic Act relating to the introduction of adulterated or


Break on through to the other side: an update on Breakthrough Therapy designation requests
  • Arnall Golden Gregory LLP
  • USA
  • May 27 2015

A recent public meeting on Breakthrough Therapy (BT) Designation after 2 years from implementation provided some interesting insight and trend


WHO rejects U.S.’s appeal regarding its COOL measures
  • Alston & Bird LLP
  • Canada, Mexico, USA
  • May 27 2015

On Monday, May 18, 2015, the World Trade Organization issued a compliance panel report in the case regarding the U.S.'s country of origin labeling


Plaintiffs filing suit for design defects or inadequate warnings may carry burden of proof on reasonable foreseeability
  • Porter Wright Morris & Arthur LLP
  • USA
  • May 27 2015

On May 4, the Sixth Circuit Court of Appeals made clear a plaintiff's burden in bringing a design defect or inadequate warnings claim under the Ohio


Malcolm Gladwell re-thinks automotive safety in "The New Yorker"
  • Foley & Lardner LLP
  • USA
  • May 26 2015

Recent high-profile product liability lawsuits against automotive manufactures have captured national attention. These cases have led to a renewed


NJ court affirms role of learned intermediary doctrine
  • Shook Hardy & Bacon LLP
  • USA
  • May 26 2015

A New Jersey court overseeing the centralized litigation regarding the human tissue product AlloDerm has issued a noteworthy ruling in a bellwether


A funny thing happened on the way to the pharmacists meeting
  • Arnall Golden Gregory LLP
  • USA
  • May 26 2015

The Food and Drug Administration's (FDA) Office of Prescription Drug Promotion (OPDP) issued recently a Notice of Violation to a generic drug company


Pharmaceutical marketing and unfair-trade-practices claims
  • Ellis & Winters
  • USA
  • May 26 2015

Lawsuits against pharmaceutical companies generally center on product-liability claims. A new trend in pharma cases, however, is to include a